American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Oppenheimer Reiterates Outperform Rating for Adobe (NASDAQ:ADBE)

Oppenheimer Reiterates Outperform Rating for Adobe (NASDAQ:ADBE)

Oppenheimer reiterated their outperform rating on shares of Adobe (NASDAQ:ADBE – Free Report) in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has a $660.00 target price on the software... More of this article »
Image about Adobe (NASDAQ:ADBE) Price Target Cut to $700.00

Adobe (NASDAQ:ADBE) Price Target Cut to $700.00

Adobe (NASDAQ:ADBE – Free Report) had its target price reduced by Piper Sandler from $705.00 to $700.00 in a research report sent to investors on Friday morning, Benzinga reports. Piper Sandler currently has an overweight rating... More of this article »
Image about Barclays Trims Adobe (NASDAQ:ADBE) Target Price to $630.00

Barclays Trims Adobe (NASDAQ:ADBE) Target Price to $630.00

Adobe (NASDAQ:ADBE – Free Report) had its price objective lowered by Barclays from $700.00 to $630.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the software... More of this article »
Image about JPMorgan Chase & Co. Trims Adobe (NASDAQ:ADBE) Target Price to $570.00

JPMorgan Chase & Co. Trims Adobe (NASDAQ:ADBE) Target Price to $570.00

Adobe (NASDAQ:ADBE – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $600.00 to $570.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a neutral rating on... More of this article »
Image about Akebia Therapeutics (NASDAQ:AKBA) Receives “Buy” Rating from HC Wainwright

Akebia Therapeutics (NASDAQ:AKBA) Receives “Buy” Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) in a research note issued to investors on Friday, Benzinga reports. The firm currently has a $5.00 price target on the biopharmaceutical... More of this article »
Image about Align Technology (NASDAQ:ALGN) Given New $350.00 Price Target at Stifel Nicolaus

Align Technology (NASDAQ:ALGN) Given New $350.00 Price Target at Stifel Nicolaus

Align Technology (NASDAQ:ALGN – Free Report) had its target price boosted by Stifel Nicolaus from $340.00 to $350.00 in a report issued on Friday morning, Benzinga reports. They currently have a buy rating on the medical equipment... More of this article »
Image about Allogene Therapeutics (NASDAQ:ALLO) Rating Reiterated by Royal Bank of Canada

Allogene Therapeutics (NASDAQ:ALLO) Rating Reiterated by Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a report published on Friday morning, Benzinga reports. They currently have a $10.00 target price on the... More of this article »
Image about Aqua Metals (NASDAQ:AQMS) Coverage Initiated by Analysts at Benchmark

Aqua Metals (NASDAQ:AQMS) Coverage Initiated by Analysts at Benchmark

Benchmark began coverage on shares of Aqua Metals (NASDAQ:AQMS – Free Report) in a research note released on Friday, Benzinga reports. The firm issued a speculative buy rating and a $2.00 target price on the business services... More of this article »
Image about JMP Securities Boosts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $10.00

JMP Securities Boosts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $10.00

Aquestive Therapeutics (NASDAQ:AQST – Free Report) had its price target hoisted by JMP Securities from $8.00 to $10.00 in a research report report published on Friday, Benzinga reports. They currently have an outperform rating... More of this article »
Image about Gruma, S.A.B. de C.V. (OTCMKTS:GPAGF) Short Interest Up 11.0% in February

Gruma, S.A.B. de C.V. (OTCMKTS:GPAGF) Short Interest Up 11.0% in February

Gruma, S.A.B. de C.V. (OTCMKTS:GPAGF – Get Free Report) saw a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 217,500 shares, a growth of 11.0% from... More of this article »
Image about Bank7 Corp. (NASDAQ:BSVN) Short Interest Update

Bank7 Corp. (NASDAQ:BSVN) Short Interest Update

Bank7 Corp. (NASDAQ:BSVN – Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 35,000 shares, an increase of 11.1% from... More of this article »
Image about EOG Resources, Inc. (NYSE:EOG) Sees Large Growth in Short Interest

EOG Resources, Inc. (NYSE:EOG) Sees Large Growth in Short Interest

EOG Resources, Inc. (NYSE:EOG – Get Free Report) was the target of a large increase in short interest in February. As of February 29th, there was short interest totalling 7,630,000 shares, an increase of 11.1% from the February... More of this article »
Image about Chatham Lodging Trust (NYSE:CLDT) Sees Large Increase in Short Interest

Chatham Lodging Trust (NYSE:CLDT) Sees Large Increase in Short Interest

Chatham Lodging Trust (NYSE:CLDT – Get Free Report) was the target of a large growth in short interest in February. As of February 29th, there was short interest totalling 556,600 shares, a growth of 11.0% from the February... More of this article »
Image about Brookfield Asset Management Ltd. (NYSE:BAM) Receives Average Rating of “Moderate Buy” from Brokerages

Brookfield Asset Management Ltd. (NYSE:BAM) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) have been assigned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the company, Marketbeat.com... More of this article »
Image about Short Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Grows By 11.0%

Short Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Grows By 11.0%

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) saw a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 5,140,000 shares, an increase of 11.0% from... More of this article »